
Balkan Medical Journal, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 15, 2025
Colorectal cancer (CRC) presents an enormous burden on cancerrelated deaths and ranks third in cancer-associated mortality both men women worldwide. 1CRC develops when stem cells at the base of colon's crypts experience genetic epigenetic alterations.Normal become cancerous because these changes, which disrupts delicate balance between oncogenes tumor suppressor genes. 1 Surgery, chemotherapy, radiation, immunotherapy, targeted therapy are routine therapies for CRC.Nonetheless, depending CRC subtype, prognosis following chemotherapy varies considerably. 2More than 20% incidences linked to long-term inflammation often observed patients with inflammatory bowel disease (IBD).This type CRC, called colitis-associated colorectal (CAC), is common IBD.
Language: Английский